Literature DB >> 14723606

Review article: registered nurse-administered propofol sedation for endoscopy.

S C Chen1, D K Rex.   

Abstract

Propofol has several attractive properties that render it a potential alternative sedative agent for endoscopy. Compared with meperidine and midazolam, it has an ultra-short onset of action, short plasma half-life, short time to achieve sedation, faster time to recovery and discharge, and results in higher patient satisfaction. Shorter times to achieve sedation enhance efficiency in the endoscopy unit. Multiple studies have documented the safe administration of propofol by non-anaesthesiologists. Administration by registered nurses is more cost-effective than administration by anaesthesiologists. However, the administration of propofol by a registered nurse supervised only by the endoscopist is controversial because the drug has the potential to produce sudden and severe respiratory depression. More information is needed on how training nurses and endoscopists should proceed to give propofol, as well as the optimal level of monitoring to ensure the safety of nurse-administered propofol.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14723606     DOI: 10.1111/j.0269-2813.2004.01833.x

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN: 0269-2813            Impact factor:   8.171


  20 in total

Review 1.  Gastroenterology services in the UK. The burden of disease, and the organisation and delivery of services for gastrointestinal and liver disorders: a review of the evidence.

Authors:  J G Williams; S E Roberts; M F Ali; W Y Cheung; D R Cohen; G Demery; A Edwards; M Greer; M D Hellier; H A Hutchings; B Ip; M F Longo; I T Russell; H A Snooks; J C Williams
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 2.  Endoscopist-directed propofol: pros and cons.

Authors:  Eun Hye Kim; Sang Kil Lee
Journal:  Clin Endosc       Date:  2014-03-31

3.  Nurse-administered propofol sedation is safe for patients with obstructive sleep apnea undergoing routine endoscopy: a pilot study.

Authors:  Douglas G Adler; Chad Kawa; Kristen Hilden; John Fang
Journal:  Dig Dis Sci       Date:  2011-03-05       Impact factor: 3.199

4.  Deep sedation during gastrointestinal endoscopy: propofol-fentanyl and midazolam-fentanyl regimens.

Authors:  Marcos Eduardo Lera dos Santos; Fauze Maluf-Filho; Dalton Marques Chaves; Sergio Eiji Matuguma; Edson Ide; Gustavo de Oliveira Luz; Thiago Ferreira de Souza; Fernanda C Simões Pessorrusso; Eduardo Guimarães Hourneaux de Moura; Paulo Sakai
Journal:  World J Gastroenterol       Date:  2013-06-14       Impact factor: 5.742

5.  Safety of Target-Controlled Propofol Infusion by Gastroenterologists in Patients Undergoing Endoscopic Resection.

Authors:  Seung In Seo; Ji Yon Ryu; Sang Soo Kang; Jin Seo Lee; Hyoung Su Kim; Myoung Kuk Jang; Hak Yang Kim; Woon Geon Shin
Journal:  Dig Dis Sci       Date:  2016-08-01       Impact factor: 3.199

Review 6.  The Role of GABA Receptor Agonists in Anesthesia and Sedation.

Authors:  Janette Brohan; Basavana G Goudra
Journal:  CNS Drugs       Date:  2017-10       Impact factor: 5.749

7.  Sedation levels during propofol administration for outpatient colonoscopies.

Authors:  Michael A E Ramsay; Kate B Newman; Robert M Jacobson; Charles T Richardson; Lindsay Rogers; Bertrand J Brown; H A Tillmann Hein; Edward B De Vol; Yahya A Daoud
Journal:  Proc (Bayl Univ Med Cent)       Date:  2014-01

8.  Bispectral index monitoring for nurse-administered propofol sedation during upper endoscopic ultrasound: a prospective, randomized controlled trial.

Authors:  John M DeWitt
Journal:  Dig Dis Sci       Date:  2008-02-15       Impact factor: 3.199

9.  Propofol use for sedation during endoscopy in adults: a Canadian Association of Gastroenterology position statement.

Authors:  Michael F Byrne; Naoki Chiba; Harminder Singh; Daniel C Sadowski
Journal:  Can J Gastroenterol       Date:  2008-05       Impact factor: 3.522

10.  Monitored anesthesia care (MAC) sedation: clinical utility of fospropofol.

Authors:  Eric A Harris; David A Lubarsky; Keith A Candiotti
Journal:  Ther Clin Risk Manag       Date:  2009-12-29       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.